Analysis of FAZ in Diabetic Retinopathy Using OCT Angiography
Launched by KAREEM MOHAMMAD ALI · Nov 17, 2021
Trial Information
Current as of May 15, 2025
Unknown status
Keywords
ClinConnect Summary
OCTA is superior to other retinal imaging techniques like fluorescein angiography(FA) as it does not require dye injection, Intravenous dye injection is time consuming and can have adverse side effects. Furthermore, the edges of the capillaries can become blurred due to dye leakage and imaging of the retina can only be 2D when using FA.
OCTA provides both structural and functional (i.e. blood flow) information in tandem. The "corresponding" OCT b-scans can be co-registered with the simultaneous OCT angiograms so the operator is able to scroll through the OCT angiogram like a cube scan. As ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diabetic patients suffering from different stages of diabetic retinopathy.
- Exclusion Criteria:
- • Other ocular problems affecting vision including glaucoma, cataract, amblyopia, hypertensive retinopathy, vein occlusion and uveitis.
About Kareem Mohammad Ali
Kareem Mohammad Ali is a dedicated clinical trial sponsor committed to advancing medical research through innovative and ethically conducted studies. With a focus on enhancing patient outcomes, Mr. Ali leads initiatives that prioritize rigorous scientific methodology and regulatory compliance. His extensive experience in clinical trial management and a deep understanding of therapeutic landscapes enable him to foster collaborations with healthcare professionals, researchers, and regulatory bodies. By leveraging cutting-edge technologies and a patient-centric approach, he aims to facilitate the development of new therapies that address unmet medical needs and improve health care delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ziad Hn El Daly, MD
Study Chair
Assuit Universoty
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials